Comparing Baseline Data From Registries With Trials: Evidence From the CathPCI Registry and DAPT Study.
作者信息
Butala Neel M, Faridi Kamil F, Secemsky Eric A, Song Yang, Curtis Jeptha, Gibson C Michael, Brindis Ralph, Shen Changyu, Yeh Robert W
出版信息
JACC Cardiovasc Interv. 2021 Jun 28;14(12):1386-1388. doi: 10.1016/j.jcin.2021.03.065.
Abstract
摘要
相似文献
1
Comparing Baseline Data From Registries With Trials: Evidence From the CathPCI Registry and DAPT Study.
JACC Cardiovasc Interv. 2021 Jun 28;14(12):1386-1388. doi: 10.1016/j.jcin.2021.03.065.
2
Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population.
Circ Cardiovasc Interv. 2018 Oct;11(10):e006853. doi: 10.1161/CIRCINTERVENTIONS.118.006853.
3
Outcomes of prolonged dual anti-platelet therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A nationwide registry-based study.
Am Heart J. 2022 Mar;245:81-89. doi: 10.1016/j.ahj.2021.11.018. Epub 2021 Dec 10.
4
Predictive ability of longitudinal changes in PRECISE-DAPT score in patients on dual antiplatelet therapy: The RE-SCORE multicentre prospective registry.
Eur J Prev Cardiol. 2021 Oct 13;28(12):e36-e38. doi: 10.1177/2047487320937846. Epub 2020 Jul 5.
5
Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data Registry.
Circ Cardiovasc Qual Outcomes. 2015 Jan;8(1):96-102. doi: 10.1161/CIRCOUTCOMES.114.001239. Epub 2014 Nov 16.
6
Validating Utility of Dual Antiplatelet Therapy Score in a Large Pooled Cohort From 3 Japanese Percutaneous Coronary Intervention Studies.
Circulation. 2018 Feb 6;137(6):551-562. doi: 10.1161/CIRCULATIONAHA.117.028924. Epub 2017 Oct 5.
7
Value of DAPT score to predict adverse outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: A post-hoc analysis from the AFCAS registry.
Int J Cardiol. 2018 Feb 15;253:35-39. doi: 10.1016/j.ijcard.2017.07.074.
8
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry.
JACC Cardiovasc Interv. 2017 Apr 10;10(7):645-654. doi: 10.1016/j.jcin.2016.12.003. Epub 2017 Mar 15.
9
Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients).
Circ Cardiovasc Interv. 2018 Mar;11(3):e006144. doi: 10.1161/CIRCINTERVENTIONS.117.006144.
10
The Importance of the Mean Platelet Aggregation Degree in Long-term Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation.
Cardiovasc Ther. 2016 Jun;34(3):127-37. doi: 10.1111/1755-5922.12177.
引用本文的文献
1
Use of Calcium Modification During Percutaneous Coronary Intervention After Introduction of Coronary Intravascular Lithotripsy.
J Soc Cardiovasc Angiogr Interv. 2024 Jan 22;3(2):101254. doi: 10.1016/j.jscai.2023.101254. eCollection 2024 Feb.
本文引用的文献
1
Comparability of Event Adjudication Versus Administrative Billing Claims for Outcome Ascertainment in the DAPT Study: Findings From the EXTEND-DAPT Study.
Circ Cardiovasc Qual Outcomes. 2021 Jan;14(1):e006589. doi: 10.1161/CIRCOUTCOMES.120.006589. Epub 2021 Jan 13.
2
Validating the use of registries and claims data to support randomized trials: Rationale and design of the Extending Trial-Based Evaluations of Medical Therapies Using Novel Sources of Data (EXTEND) Study.
Am Heart J. 2019 Jun;212:64-71. doi: 10.1016/j.ahj.2019.02.007. Epub 2019 Mar 6.
3
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.
N Engl J Med. 2014 Dec 4;371(23):2155-66. doi: 10.1056/NEJMoa1409312. Epub 2014 Nov 16.
4
A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial.
JACC Cardiovasc Interv. 2014 Aug;7(8):857-67. doi: 10.1016/j.jcin.2014.04.007.
5
Thrombus aspiration during ST-segment elevation myocardial infarction.
N Engl J Med. 2013 Oct 24;369(17):1587-97. doi: 10.1056/NEJMoa1308789. Epub 2013 Aug 31.
6
Standardized cardiovascular data for clinical research, registries, and patient care: a report from the Data Standards Workgroup of the National Cardiovascular Research Infrastructure project.
J Am Coll Cardiol. 2013 May 7;61(18):1835-46. doi: 10.1016/j.jacc.2012.12.047. Epub 2013 Mar 6.
Zotero 插件